


RNAble Email Formats
Biotechnology Research • Nes Ziona, Center District, Israel • 1-10 Employees
RNAble Email Formats
RNAble uses 1 email format. The most common is {first name} (e.g., john@futurx.co.il), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@futurx.co.il | 100% |
Key Contact at RNAble
Amir Mor
Chief Scientific Officer And Co-Founder
Company overview
| Headquarters | Ilan Ramon Street 2, 3rd floor, Ness Ziona, 7404905, IL |
| Phone number | +97289553100 |
| Website | |
| Keywords | RNA, Cancer, Small Molecule |
| Founded | 2021 |
| Employees | 1-10 |
| Socials |
About RNAble
RNAble is a preclinical biotechnology company developing a potent small-molecule inhibitor targeting FTO, a key driver of oncogenic RNA biology. Mechanistic studies have led to the identification of a specific biomarker that predicts pan-cancer sensitivity to the inhibitor across both hematological and solid malignancies. Key highlights of RNAble's lead candidate: • Demonstrates strong in vivo efficacy and superior antitumor activity compared to standard-of-care therapies in AML models. • Shows promising efficacy in preclinical models of biomarker-selected solid tumors. • Features a novel, validated mechanism of action that induces cancer cell death via RNA-mediated mitotic catastrophe followed by apoptosis, with potential to overcome resistance to current therapies. • Exhibits strong oral bioavailability and a favorable safety profile. • Expected IND submission in 2026.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
RNAble has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
RNAble has never raised funding before.
Frequently asked questions
4.8
40,000 users



